Janux Therapeutics JANX
NASDAQ JANX
$16.94 +0.36 (+2.17%)
As of: Sep 29, 2026 · 3:59 PM EDT

Janux Therapeutics (JANX) Research & Development (2020 - 2026)

Updated

Janux Therapeutics' Research & Development was $30.99 million in Q2 2026, down 10.6% from $34.66 million a year earlier but up 15.6% from the prior quarter.

Analysis

Janux Therapeutics (JANX) Research & Development (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Janux Therapeutics' Research & Development was $123.98 million through Jun 30, 2026, up 25.1% year-over-year; for FY2025, it came in at $125.9 million, up 84.1% from FY2024.

  • Research & Development has now increased for five consecutive years, with a five-year compound annual growth rate of 110.6% (FY2020 to FY2025).
  • In earlier years, Research & Development was $68.39 million in FY2024 (+24.5%), $54.92 million in FY2023 (+2.8%), $53.44 million in FY2022 (+103.7%) and $26.24 million in FY2021 (+762.8%).
  • Quarterly Research & Development has moved between $8.41 million (Q3 2021) and $34.66 million (Q2 2025) over five years.
  • Compared with a year earlier, Research & Development was higher in seven of the last eight quarters, with growth averaging 58.9%.
  • The best year-over-year quarter for Research & Development over five years was Q3 2021 (growth of 907.9%); the worst was Q4 2023 (a decline of 20.7%).
  • Per Business Quant data, JANX's Research & Development in the three quarters before Q2 2026 was $26.81 million (Q1 2026), $31.55 million (Q4 2025) and $34.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Janux Therapeutics 1.01 Bn 1.01 Bn - 30.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.99 Mn
Mar 31, 2026 26.81 Mn
Dec 31, 2025 31.55 Mn
Sep 30, 2025 34.63 Mn
Jun 30, 2025 34.66 Mn
Mar 31, 2025 25.06 Mn
Dec 31, 2024 20.81 Mn
Sep 30, 2024 18.61 Mn
Jun 30, 2024 14.90 Mn
Mar 31, 2024 14.07 Mn
Dec 31, 2023 12.24 Mn
Sep 30, 2023 11.89 Mn
Jun 30, 2023 14.92 Mn
Mar 31, 2023 15.87 Mn
Dec 31, 2022 15.43 Mn
Sep 30, 2022 13.74 Mn
Jun 30, 2022 14.09 Mn
Mar 31, 2022 10.18 Mn
Dec 31, 2021 11.17 Mn
Sep 30, 2021 8.41 Mn
API Access

Janux Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=JANX&period=max&api_key=YOUR_API_KEY